Insider Selling: Vanda Pharmaceuticals Inc (NASDAQ:VNDA) CMO Sells 3,724 Shares of Stock kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Rating) in a report released on Thursday morning. The brokerage issued a strong-buy rating on the biopharmaceutical company’s stock. Vanda Pharmaceuticals Trading Up 1.5 % NASDAQ VNDA opened at $6.20 on Thursday. The firm has a market cap of $356.13 million, a price-to-earnings ratio […]
StockNews.com initiated coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Get Rating) in a research note published on Thursday. The firm issued a strong-buy rating on the biopharmaceutical company’s stock. Vanda Pharmaceuticals Stock Down 1.6 % Shares of VNDA opened at $6.11 on Thursday. The company has a 50-day simple moving average of $6.53 and […]
Capital Advisors Ltd. LLC purchased a new stake in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 5,000 shares of the biopharmaceutical company’s stock, valued at approximately $37,000. Several other […]
KBC Group NV lessened its holdings in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Rating) by 49.6% during the 2nd quarter, Holdings Channel reports. The firm owned 5,483 shares of the biopharmaceutical company’s stock after selling 5,389 shares during the period. KBC Group NV’s holdings in Vanda Pharmaceuticals were worth $60,000 as of its […]